Relay Therapeutics, Inc. (RLAY) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts RLAY Hot Sheet
Join SI Premium – FREE
Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q2 EPS of ($0.69), $0.04 better than the analyst estimate of ($0.73).
For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Upgrades China Resources Microelectronics Ltd (688396:CH) to Neutral
- Goldman Sachs Double Upgrades Bradsaude SA (SAUD3:BZ) to Buy
- Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
